DE602005024357D1 - Benzamidin Derivative zur Behandlung und Vorbeugung von Mucositis - Google Patents

Benzamidin Derivative zur Behandlung und Vorbeugung von Mucositis

Info

Publication number
DE602005024357D1
DE602005024357D1 DE602005024357T DE602005024357T DE602005024357D1 DE 602005024357 D1 DE602005024357 D1 DE 602005024357D1 DE 602005024357 T DE602005024357 T DE 602005024357T DE 602005024357 T DE602005024357 T DE 602005024357T DE 602005024357 D1 DE602005024357 D1 DE 602005024357D1
Authority
DE
Germany
Prior art keywords
mucositis
benzamidine derivatives
prevention
treatment
epitelium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005024357T
Other languages
English (en)
Inventor
Ornella Letari
Amato Massimo Maria D
Simona Zanzola
Roberto Artusi
Lucio Claudio Rovati
Gianfranco Caselli
Antonio Giordani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rottapharm SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm SpA filed Critical Rottapharm SpA
Publication of DE602005024357D1 publication Critical patent/DE602005024357D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE602005024357T 2005-03-24 2005-03-24 Benzamidin Derivative zur Behandlung und Vorbeugung von Mucositis Active DE602005024357D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102423A EP1704860B1 (de) 2005-03-24 2005-03-24 Benzamidin Derivative zur Behandlung und Vorbeugung von Mucositis

Publications (1)

Publication Number Publication Date
DE602005024357D1 true DE602005024357D1 (de) 2010-12-09

Family

ID=35058092

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024357T Active DE602005024357D1 (de) 2005-03-24 2005-03-24 Benzamidin Derivative zur Behandlung und Vorbeugung von Mucositis

Country Status (13)

Country Link
US (1) US20080194877A1 (de)
EP (1) EP1704860B1 (de)
JP (1) JP5020227B2 (de)
AT (1) ATE485819T1 (de)
AU (1) AU2006226390B2 (de)
CA (1) CA2600773C (de)
DE (1) DE602005024357D1 (de)
DK (1) DK1704860T3 (de)
ES (1) ES2351665T3 (de)
HK (1) HK1095285A1 (de)
PL (1) PL1704860T3 (de)
PT (1) PT1704860E (de)
WO (1) WO2006100204A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
US8802683B2 (en) 2011-05-16 2014-08-12 Cellceutix Corporation Compounds for use in treatment of mucositis
FR2979241B1 (fr) 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
WO2013175377A2 (en) * 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of mucositis
US20160199338A1 (en) 2013-08-19 2016-07-14 Enzychem Lifesciences Corporation Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis
EP3142657B1 (de) 2014-05-15 2019-09-11 Enzychem Lifesciences Corporation Verfahren zur behandlung von neutropenie
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
WO2022265993A1 (en) 2021-06-14 2022-12-22 Scorpion Therapeutics, Inc. Urea derivatives which can be used to treat cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458777B1 (en) * 1998-03-13 2002-10-01 Mucosal Therapeutics Llc Methods and compositions for treating and preventing mucositis
ITTO20010110A1 (it) * 2001-02-08 2002-08-08 Rotta Research Lab Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.

Also Published As

Publication number Publication date
DK1704860T3 (da) 2011-02-07
PT1704860E (pt) 2010-11-16
AU2006226390A1 (en) 2006-09-28
HK1095285A1 (en) 2007-05-04
WO2006100204A1 (en) 2006-09-28
ATE485819T1 (de) 2010-11-15
EP1704860A1 (de) 2006-09-27
ES2351665T3 (es) 2011-02-09
JP2008534471A (ja) 2008-08-28
US20080194877A1 (en) 2008-08-14
EP1704860B1 (de) 2010-10-27
CA2600773C (en) 2013-06-11
PL1704860T3 (pl) 2011-04-29
JP5020227B2 (ja) 2012-09-05
CA2600773A1 (en) 2006-09-28
AU2006226390B2 (en) 2011-09-08

Similar Documents

Publication Publication Date Title
ATE485819T1 (de) Benzamidin derivative zur behandlung und vorbeugung von mucositis
EA200802332A1 (ru) Пирролопиримидины и их применение
DE602006020353D1 (de) Progesterone Dosierungsanweisung in der Behandlung einer traumatischen Verletzung des Gehirns
WO2004073630A3 (en) Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
NO20061325L (no) Kombinasjon av legemidler for behandling av neoplasmer
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
DE602005013811D1 (de) Behandlung von fettsucht und verbundenen erkrankungen
DE60216139D1 (de) Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen
ATE542801T1 (de) Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
ATE381935T1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
DE602005020293D1 (de) Zur behandlung von hyperproliferationserkrankungen und mit angiogenese assoziierten krankheiten geeignete pyrrolotriazinderivate
DE602007005120D1 (de) 2-pyridonderivate zur behandlung von krankheiten oder leiden, bei denen eine inhibierung der aktivität der neutrophilen elastase von nutzen ist
MY140132A (en) Thiazolidin-4-one derivatives for use in the treatment of anemias
MX2017014204A (es) Formulaciones de tpp1 y metodos para tratar la enfemedad de cln2.
IL280475A (en) A pharmaceutical composition for use in the treatment or prevention of a C5-related disease and a method for the treatment or prevention of a C5-related disease
MX2021003681A (es) Composiciones y metodos para el tratamiento de desordenes inflamatorios.
DE60324535D1 (de) Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen
DE602004001134D1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
NL1025844A1 (nl) Benzopyranverbindingen voor gebruik bij de behandeling en preventie van ontstekingsgerelateerde aandoeningen.
WO2006053014A3 (en) Selective inhibition of rock1 in cardiac therapy
BRPI0503827A (pt) métodos para prevenir ou tratar infecções respiratórias em lactentes
EA200602002A1 (ru) Применение спинозинов для заживления ран
PT3937948T (pt) Fitoecdisonas e seus derivados para utilização no tratamento de doenças neuromusculares